The Spotlight Roundup-Is California Next For Legalizing Psychedelics?

June 22, 2021- This week’s Psychedelic Business News top stories include:
– California Takes A Big Step Forward Towards Legalizing Psychedelics
– Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects On The Brain
– Mind Cure Health Inc. Completes The First Stage Of Manufacturing Pharmaceutical Grade Psychedelics for Clinical Research

AND MORE!

Read The Latest News: https://bit.ly/2SJ0ZKx

📲 SOCIAL:
Facebook: https://www.facebook.com/PsychedelicSpotlight
Instagram: https://www.instagram.com/psycspotlight/
Twitter: https://twitter.com/PsycSpotlight
LinkedIn: https://www.linkedin.com/company/psychedelic-spotlight/?viewAsMember=true

#psychedelics #business #california

source

Psychedelic Spotlight

Interview With David Dardashti, Founder of Ibogaine clinic

January 14, 2021June 2, 2024 Listen, Podcasts

David Dardashti talks about his Ibogaine clinic in Mexico, where he’s treated more than 8,500 people from trauma, addiction, and health issues.

MindMed vs. atai Life Sciences (Everything You Need to Know Before Buying MNMD / MMED/ ATAI)

June 26, 2021June 2, 2024 Listen, Videos

THE MINDMED VS. ATAI discussion you need to hear!

Prior to atai’s IPO on the NASDAQ stock exchange, we repeatedly said that when atai Life Sciences goes public, the company will become MindMed ‘s ( MNMD: NASDAQ) (MMED: NEO) top competitor.

Well, atai did IPO on June 18 under ticker symbol “atai”. For this reason, I invited Jason Najum from Microdose.buzz to have a conversation. In this episode, we have a general discussion about:

– MindMed’s flagship programs and the different businesses and programs ran under atai’s umbrella.
– The companies’ financial capability to run clinical trials.
-MindMed’s and atai’s potential to disrupt the way we treat mental illness within the next 5 to 10 years.
– Potential return on investment for retail investors.

Time Stamps:
0:00 – Intro
4:11 – What is atai’s mission?
6:24 – What is MindMed’s Mission
8:29 – atai’s clinical trial pipeline
19:45 – MindMed’s clinical trial pipeline
24:25 – How do MindMed and atai differ in business structure?
30:40 – Comparing the financials

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

Enjoy the episode!

Check out Jason’s writing at:
https://microdose.buzz/

Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com

Website: https://thepsychedelicinvestor.com/

Music from:
www.bensound.com

Video editing: @themyaholy

Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

#MindMed #MNMD #Atai

Journaling for Psychedelic Integration with Jenalle Dion, Wakeful Travel

July 27, 2022June 2, 2024 Listen, Podcasts

Jenalle talks with Spotlight about the cultivation of her journal company, Wakeful Travel, and her story of pivoting from a travel-focus to the integration space.

Real Estate and Psychedelic-Assisted Therapy with Ty Zakovich, Daniel Carcillo, and Cody Shandraw

January 12, 2023June 2, 2024 Listen, Podcasts

In this episode David Flores, CEO of Spotlight Media Corp, sits down with the founding members of the newly formed Healing REIT that will focus on investing in real estate designed for innovative medicine such as psychedelic-assisted therapy.

UFC Explores Psychedelic Therapy for Brain-Injured Fighters

March 22, 2021June 2, 2024 Listen, Psychedelic Spotlight Videos

The UFC (Ultimate Fighting Championship) is working with industry leaders to better understand brain trauma-related problems the combat sport causes athletes. As part of that effort, the organization is taking a long, hard look at psychedelic therapies as possible treatments.

The Top 10 Psychedelics Stocks’ Financials COMPARED ( Atai, CMPS, MNMD, NUMI, RVV, DMT, TRIP+)

August 28, 2021June 2, 2024 Listen, Videos

What’s up psychedelic investors! In this episode, we’ll be comparing the top 10 psychedelic stocks’ financials.
Will look at the 4 most important financial stats for each of the top 10 companies in the Psychedelic Medicines field, selected by market cap.

First, we will look at the market cap, because that tells us how valuable the market judges the company to be, and it tells us how easily a company can raise capital.
Next, we will look at cash on hand.
Third, we will look at how much a company is spending.
Finally, we will look at revenue where applicable
All figures are in American dollars.

So which stocks we’ll be comparing, you may ask? We’ll look at:
– Atai Life Sciences ( NASDAQ: ATAI)
– Compass Pathways (NASDAQ: CMPS)
-MindMed (NASDAQ: MNMD), ( NEO: MMED)
– Cybin Inc (NYSE: CYBN)
– Numinus Wellneass (TSX: NUMI) (OTC: LKYSF)
– Revive Therapeutics (CN: RVV) (OTC: RVVTF)
– Small Pharma ( TSX: DMT)
-Mydecine (OTC: MYCOF) (NEO: MYCO)
– Red Light Holland ( CSE: TRIP) (OTC: TRUFF)